Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

INTRODUCTION: Despite the benefit of adjuvant systemic therapy for patients with resected non-small cell lung cancer (NSCLC), the risk of postoperative recurrence remains high. Our objective was to characterize temporal genetic heterogeneity between primary resected and recurrent tumors, and its imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Qiyu, Wan, Xiaoying, D’Aiello, Angelica, Sun, Hui, Gu, Weiquing, Li, Yixue, Zhou, Caicun, Xie, Boxiong, Deng, Qinfang, Cheng, Haiying, Zhou, Songwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368968/
https://www.ncbi.nlm.nih.gov/pubmed/37503313
http://dx.doi.org/10.3389/fonc.2023.1116809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368968/
https://www.ncbi.nlm.nih.gov/pubmed/37503313
http://dx.doi.org/10.3389/fonc.2023.1116809

Ejemplares similares